STAT+: FDA reverses course, agrees to review Moderna’s flu vaccine
STAT [Unofficial]
February 18, 2026
The FDA reversed course and told Moderna it would review its application for a new flu vaccine, the company announced Wednesday.
Discussion in the ATmosphere